<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.jissn.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Journal of the International Society of Sports Nutrition - Latest Articles</title>
        <link>http://www.jissn.com</link>
        <description>The latest research articles published by Journal of the International Society of Sports Nutrition</description>
        <dc:date>2013-05-24T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.jissn.com/content/10/1/27" />
                                <rdf:li rdf:resource="http://www.jissn.com/content/10/1/26" />
                                <rdf:li rdf:resource="http://www.jissn.com/content/10/1/25" />
                                <rdf:li rdf:resource="http://www.jissn.com/content/10/1/24" />
                                <rdf:li rdf:resource="http://www.jissn.com/content/10/1/23" />
                                <rdf:li rdf:resource="http://www.jissn.com/content/10/1/22" />
                                <rdf:li rdf:resource="http://www.jissn.com/content/10/1/21" />
                                <rdf:li rdf:resource="http://www.jissn.com/content/10/1/20" />
                                <rdf:li rdf:resource="http://www.jissn.com/content/10/1/19" />
                                <rdf:li rdf:resource="http://www.jissn.com/content/10/1/17" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.jissn.com/content/10/1/27">
        <title>Hesperidin associated with continuous and interval swimming improved biochemical and oxidative biomarkers in rats</title>
        <description>Background:
Citrus flavonoids, such as hesperidin, have shown therapeutic properties that improve hyperglycemia and insulin resistance, and decrease blood serum lipids and inflammation. The current investigation studied the effects of hesperidin supplementation associated with continuous and interval swimming on the biochemical parameters (glucose, cholesterol and triglycerides), and oxidative stress markers (TBARS and DPPH) in rats.
Methods:
The animals (n = 60) were randomly divided in six groups: negative (C) and positive control (CH) for hesperidin supplementation, and continuous or interval swimming without (CS and IS) or with hesperidin supplementation (CSH and ISH). Hesperidin was given by gavage for four weeks (100 mg/kg body mass) before the exercise. Continuous swimming was performed for 50 min with loads from 5% to 8 % of body weight from the first to fourth week, while interval swimming training was performed for 50 min in sessions of 1 min of swimming followed by 2 min of resting, carrying loads from 10% to 15, 20 and 25% from the first to fourth week. At the end of the experiment, blood serum samples were draw to perform analysis of glucose, total cholesterol, HDL-C and triglycerides. Oxidative biomarkers were evaluated by lipid peroxidation (TBARS) and antioxidant capacity assay (DPPH) of the blood serum.
Results:
There was a continuous decline of serum glucose from C (100%) &gt; CH (97%) &gt; CS (94%) &gt; CSH (91%, p &lt; .05), IS (87%, p &lt; .05) &gt; ISH (80%, p &lt; .05), showing a combined beneficial effect of hesperidin and swimming. Also, continuous or intermittent swimming with hesperidin supplementation lowered total cholesterol (-16%, p &lt; .05), LDL-C (-50%, p &lt; 0.05) and triglycerides (-19%, p &lt; 0.05), and increased HDL-C (48%, p &lt; .05). Furthermore, hesperidin enhanced the antioxidant capacity on the continuous swimming group (183%, p &lt; .05) and lowered the lipid peroxidation on the interval swimming group (-45%, p &lt; .05).
Conclusions:
Hesperidin supplementation per se, or in combination with swimming exercise protocols, improved the biochemical profile and antioxidant biomarkers evidencing that the use of flavanones may enhance the health benefits promoted by exercise.</description>
        <link>http://www.jissn.com/content/10/1/27</link>
                <dc:creator>David de Oliveira</dc:creator>
                <dc:creator>Grace Dourado</dc:creator>
                <dc:creator>Thais Cesar</dc:creator>
                <dc:source>Journal of the International Society of Sports Nutrition 2013, null:27</dc:source>
        <dc:date>2013-05-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1550-2783-10-27</dc:identifier>
                                <prism:require>/content/figures/1550-2783-10-27-toc.gif</prism:require>
                <prism:publicationName>Journal of the International Society of Sports Nutrition</prism:publicationName>
        <prism:issn>1550-2783</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>27</prism:startingPage>
        <prism:publicationDate>2013-05-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jissn.com/content/10/1/26">
        <title>Does long-term creatine supplementation impair kidney function in resistance-trained individuals consuming a high-protein diet?</title>
        <description>Background:
The aim of this study was to determine the effects of creatine supplementation on kidney function in resistance-trained individuals ingesting a high-protein diet.
Methods:
A randomized, double-blind, placebo-controlled trial was performed. The participants were randomly allocated to receive either creatine (20 g/d for 5 d followed by 5 g/d throughout the trial) or placebo for 12 weeks. All of the participants were engaged in resistance training and consumed a high-protein diet (i.e., &#8805; 1.2 g/Kg/d). Subjects were assessed at baseline (Pre) and after 12 weeks (Post). Glomerular filtration rate was measured by 51Cr-EDTA clearance. Additionally, blood samples and a 24-h urine collection were obtained for other kidney function assessments.
Results:
No significant differences were observed for 51Cr-EDTA clearance throughout the trial (Creatine: Pre 101.42&#8201;&#177;&#8201;13.11, Post 108.78&#8201;&#177;&#8201;14.41 mL/min/1.73m2; Placebo: Pre 103.29&#8201;&#177;&#8201;17.64, Post 106.68&#8201;&#177;&#8201;16.05 mL/min/1.73m2; group x time interaction: F&#8201;=&#8201;0.21, p&#8201;=&#8201;0.64). Creatinine clearance, serum and urinary urea, electrolytes, proteinuria, and albuminuria remained virtually unchanged.
Conclusions:
A 12-week creatine supplementation protocol did not affect kidney function in resistance-trained healthy individuals consuming a high-protein diet; thus reinforcing the safety of this dietary supplement.Trial registrationClinicalTrials.gov NCT01817673</description>
        <link>http://www.jissn.com/content/10/1/26</link>
                <dc:creator>Rebeca Lugaresi</dc:creator>
                <dc:creator>Marco Leme</dc:creator>
                <dc:creator>Vítor de Salles Painelli</dc:creator>
                <dc:creator>Igor Murai</dc:creator>
                <dc:creator>Hamilton Roschel</dc:creator>
                <dc:creator>Marcelo Sapienza</dc:creator>
                <dc:creator>Antonio Lancha Junior</dc:creator>
                <dc:creator>Bruno Gualano</dc:creator>
                <dc:source>Journal of the International Society of Sports Nutrition 2013, null:26</dc:source>
        <dc:date>2013-05-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1550-2783-10-26</dc:identifier>
                            <dc:title>Creatine Rocks!</dc:title>
                            <dc:description>More evidence to show that creatine is safe.</dc:description>
                <prism:require>/content/figures/1550-2783-10-26-toc.gif</prism:require>
                <prism:publicationName>Journal of the International Society of Sports Nutrition</prism:publicationName>
        <prism:issn>1550-2783</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>26</prism:startingPage>
        <prism:publicationDate>2013-05-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jissn.com/content/10/1/25">
        <title>Effects of ingestion of a commercially available thermogenic dietary supplement on resting energy expenditure, mood state and cardiovascular measures</title>
        <description>Background:
Increasing metabolism is a primary focus of many commercially available dietary supplements marketed to support weight management. Caffeine (e.g. anhydrous and herbal) and green tea are key ingredients in such products, augmenting resting energy expenditure (REE) and improving reported mood states (alertness, fatigue, focus, etc.). The purpose of this study was to evaluate the effects of a thermogenic dietary supplement (DBX) on REE, respiratory exchange ratio (RER), reported measures of alertness, focus, energy, concentration, fatigue, and hunger, as well as the general safety of the product based on electrocardiogram (ECG) and hemodynamic responses in habitual caffeine consumers.
Methods:
Six male and six female subjects (mean &#177; SD; 22.50&#8201;&#177;&#8201;3.22 years; 76.94&#8201;&#177;&#8201;14.78 kg; 22.7&#8201;&#177;&#8201;9.5% body fat), physically active (&#8805;12 months), and moderate habitual caffeine consumers (&lt;200 mg/day) received either two capsules of DBX containing 340 mg of total caffeine plus green tea extract, yerba mate extract, carnitine tartrate and other active ingredients or a placebo (PLC) in a double-blinded, crossover design. Heart rate (HR), blood pressure (BP), REE, RER and perceived mood states were measured at baseline and then hourly for four hours after ingesting either treatment.
Results:
Resting energy expenditure was significantly increased at all four time points and significant increases were determined for perceived alertness (p&#8201;=&#8201;0.026) and focus (p&#8201;=&#8201;0.05) at hour 1 and for energy at 1 and 2 hours after treatment for the DBX group (p&#8201;=&#8201;0.008 and p&#8201;=&#8201;0.017, respectively). Additionally, perceived fatigue was decreased at the hour 1 assessment (p&#8201;=&#8201;0.010). No significant differences were seen between DBX and placebo for hunger, anxiety, HR, BP, ECG patterns or RER.
Conclusions:
The results of this investigation support that the proprietary blend of this thermogenic aid is capable of increasing REE for four hours post-ingestion while supporting increased focus, alertness, and energy as well as decreasing fatigue without promoting anxiety or causing significant changes in HR, BP, or ECG measurements in habitual caffeine consumers.</description>
        <link>http://www.jissn.com/content/10/1/25</link>
                <dc:creator>Jordan Outlaw</dc:creator>
                <dc:creator>Colin Wilborn</dc:creator>
                <dc:creator>Abbie Smith</dc:creator>
                <dc:creator>Stacie Urbina</dc:creator>
                <dc:creator>Sara Hayward</dc:creator>
                <dc:creator>Cliffa Foster</dc:creator>
                <dc:creator>Shawn Wells</dc:creator>
                <dc:creator>Rob Wildman</dc:creator>
                <dc:creator>Lem Taylor</dc:creator>
                <dc:source>Journal of the International Society of Sports Nutrition 2013, null:25</dc:source>
        <dc:date>2013-04-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1550-2783-10-25</dc:identifier>
                                <prism:require>/content/figures/1550-2783-10-25-toc.gif</prism:require>
                <prism:publicationName>Journal of the International Society of Sports Nutrition</prism:publicationName>
        <prism:issn>1550-2783</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>25</prism:startingPage>
        <prism:publicationDate>2013-04-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jissn.com/content/10/1/24">
        <title>Ubiquinol supplementation enhances peak power production in trained athletes: a double-blind, placebo controlled study</title>
        <description>Background:
To investigate the effect of Ubiquinol supplementation on physical performance measured as maximum power output in young and healthy elite trained athletes.
Methods:
In this double-blind, placebo-controlled study, 100 young German well trained athletes (53 male, 47 female, age 19.9&#8201;&#177;&#8201;2.3&#160;years) received either 300&#160;mg Ubiquinol or placebo for 6&#160;weeks. Athletes had to perform a maximum power output test and the performance in W/kg of bodyweight was measured at the 4&#160;mmol lactate threshold on a cycling ergometer before the supplementation treatment (T1), after 3&#160;weeks (T2) and after 6&#160;weeks (T3) of treatment. In these 6&#160;weeks all athletes trained individually in preparation for the Olympic Games in London 2012. The maximum power output was measured in Watt/kilogram body weight (W/kg bw).
Results:
Both groups, placebo and Ubiquinol, significantly increased their physical performance measured as maximum power output over the treatment period from T1 to T3. The placebo group increased from 3.64&#8201;&#177;&#8201;0.49&#160;W/kg bw to 3.94&#8201;&#177;&#8201;0.47&#160;W/kg bw which is an increase of +0.30&#8201;&#177;&#8201;0.18&#160;W/kg bw or +8.5% (&#177;5.7). The Ubiquinol group increased performance levels from 3.70&#160;W/kg bw (&#177;0.56) to 4.08&#160;W/kg bw (&#177;0.48) from time point T1 to T3 which is an increase of +0.38&#8201;&#177;&#8201;0.22&#160;W/kg bw or +11.0% (&#177;8.2). The absolute difference in the enhancement of the physical performance between the placebo and the Ubiquinol group of +0.08&#160;W/kg bodyweight was significant (p&#8201;&lt;&#8201;0.03).
Conclusions:
This study demonstrates that daily supplementation of 300&#160;mg Ubiquinol for 6&#160;weeks significantly enhanced physical performance measured as maximum power output by +0.08&#160;W/kg bw (+2.5%) versus placebo in young healthy trained German Olympic athletes. While adherence to a training regimen itself resulted in an improvement in peak power output, as observed by improvement in placebo, the effect of Ubiquinol supplementation significantly enhanced peak power production in comparison to placebo.</description>
        <link>http://www.jissn.com/content/10/1/24</link>
                <dc:creator>Dietmar Alf</dc:creator>
                <dc:creator>Michael Schmidt</dc:creator>
                <dc:creator>Stefan Siebrecht</dc:creator>
                <dc:source>Journal of the International Society of Sports Nutrition 2013, null:24</dc:source>
        <dc:date>2013-04-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1550-2783-10-24</dc:identifier>
                                <prism:require>/content/figures/1550-2783-10-24-toc.gif</prism:require>
                <prism:publicationName>Journal of the International Society of Sports Nutrition</prism:publicationName>
        <prism:issn>1550-2783</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>24</prism:startingPage>
        <prism:publicationDate>2013-04-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jissn.com/content/10/1/23">
        <title>Effect of fed- versus fasted state resistance training during Ramadan on body composition and selected metabolic parameters in bodybuilders</title>
        <description>Background:
Muslim bodybuilders often continue training during Ramadan. However, the effect of resistance training in a fasted versus a fed state during Ramadan on body composition and metabolic parameters in bodybuilders is not well known. The aim of this study was to evaluate the effects of resistance training in a fasted versus a fed state during Ramadan on body composition and metabolic parameters in bodybuilders.
Methods:
Sixteen men were allocated to two groups: Eight practicing resistance training in the late afternoon in a fasted state (FAST), and eight training in the late evening in an acutely fed state (FED) during Ramadan. All visited the laboratory in the morning two days before the start of Ramadan (Bef-R) and on the 29th day of Ramadan (End-R) for anthropometric measurement, completion of a dietary questionnaire, and provision of fasting blood and urine samples.
Results:
Body mass and body fat percentage remained unchanged in FAST and FED during the whole period of the investigation. Both FAST and FED experienced an increase in the following parameters from Bef-R to End-R: urine specific gravity (1%; p&#8201;=&#8201;0.028, p&#8201;=&#8201;0.004 respectively), serum concentrations of urea (4%, p&#8201;=&#8201;0.006; 7%, p&#8201;=&#8201;0.004 respectively), creatinine (5%, p&#8201;=&#8201;0.015; 6%, p&#8201;=&#8201;0.04 respectively), uric acid (17%; p&#8201;&lt;&#8201;0.001, p&#8201;=&#8201;0.04 respectively), sodium (1%; p&#8201;=&#8201;0.029, p&#8201;=&#8201;0.019 respectively), chloride (2%; p&#8201;=&#8201;0.039, p&#8201;=&#8201;0.004 respectively), and high-density lipoprotein cholesterol (11%, p&#8201;=&#8201;0.04; 10%, p&#8201;=&#8201;0.04 respectively).
Conclusion:
Hypertrophic training in a fasted or in a fed state during Ramadan does not affect body mass and body composition of bodybuilders. Additionally, Ramadan fasting induced changes in urinary and some biochemical parameters, but these changes were not different according to when the training occurred.</description>
        <link>http://www.jissn.com/content/10/1/23</link>
                <dc:creator>Khaled Trabelsi</dc:creator>
                <dc:creator>Stephen Stannard</dc:creator>
                <dc:creator>Zohra Ghlissi</dc:creator>
                <dc:creator>Ronald Maughan</dc:creator>
                <dc:creator>Choumous Kallel</dc:creator>
                <dc:creator>Kamel Jamoussi</dc:creator>
                <dc:creator>Khaled Zeghal</dc:creator>
                <dc:creator>Ahmed Hakim</dc:creator>
                <dc:source>Journal of the International Society of Sports Nutrition 2013, null:23</dc:source>
        <dc:date>2013-04-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1550-2783-10-23</dc:identifier>
                                <prism:require>/content/figures/1550-2783-10-23-toc.gif</prism:require>
                <prism:publicationName>Journal of the International Society of Sports Nutrition</prism:publicationName>
        <prism:issn>1550-2783</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>23</prism:startingPage>
        <prism:publicationDate>2013-04-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jissn.com/content/10/1/22">
        <title>Eight weeks of supplementation with a multi-ingredient weight loss product enhances body composition, reduces hip and waist girth, and increases energy levels in overweight men and women</title>
        <description>Background:
Numerous natural products are marketed and sold claiming to decrease body weight and fat, but few undergo finished product-specific research demonstrating their safety and efficacy.ObjectiveTo determine the safety and efficacy of a multi-ingredient supplement containing primarily raspberry ketone, caffeine, capsaicin, garlic, ginger and Citrus aurantium (Prograde Metabolism&#8482; [METABO]) as an adjunct to an eight-week weight loss program.
Methods:
Using a randomized, placebo-controlled, double-blind design, 70 obese but otherwise healthy subjects were randomly assigned to METABO or a placebo and underwent 8&#8201;weeks of daily supplementation, a calorie restricted diet, and exercise training. Subjects were tested for changes in body composition, serum adipocytokines (adiponectin, resistin, leptin, TNF-&#945;, IL-6) and markers of health including heart rate and blood pressure.
Results:
Of the 45 subjects who completed the study, significant differences were observed in: body weight (METABO -2.0% vs. placebo -0.5%, P&#8201;&lt;&#8201;0.01), fat mass (METABO -7.8 vs. placebo -2.8%, P&#8201;&lt;&#8201;0.001), lean mass (METABO +3.4% vs. placebo +0.8%, P&#8201;&lt;&#8201;0.03), waist girth (METABO -2.0% vs. placebo -0.2%, P&#8201;&lt;&#8201;0.0007), hip girth (METABO -1.7% vs. placebo -0.4%, P&#8201;&lt;&#8201;0.003), and energy levels per anchored visual analogue scale (VAS) (METABO +29.3% vs. placebo +5.1%, P&#8201;&lt;&#8201;0.04). During the first 4&#8201;weeks, effects/trends for maintaining elevated serum leptin (P&#8201;&lt;&#8201;0.03) and decreased serum resistin (P&#8201;&lt;&#8201;0.08) in the METABO group vs. placebo were also observed. No changes in systemic hemodynamics, clinical blood chemistries, adverse events, or dietary intake were noted between groups.
Conclusions:
METABO administration is a safe and effective adjunct to an eight-week diet and exercise weight loss program by augmenting improvements in body composition, waist and hip girth. Adherence to the eight-week weight loss program also led to beneficial changes in body fat in placebo. Ongoing studies to confirm these results and clarify the mechanisms (i.e., biochemical and neuroendocrine mediators) by which METABO exerts the observed salutary effects are being conducted.</description>
        <link>http://www.jissn.com/content/10/1/22</link>
                <dc:creator>Hector Lopez</dc:creator>
                <dc:creator>Tim Ziegenfuss</dc:creator>
                <dc:creator>Jennifer Hofheins</dc:creator>
                <dc:creator>Scott Habowski</dc:creator>
                <dc:creator>Shawn Arent</dc:creator>
                <dc:creator>Joseph Weir</dc:creator>
                <dc:creator>Arny Ferrando</dc:creator>
                <dc:source>Journal of the International Society of Sports Nutrition 2013, null:22</dc:source>
        <dc:date>2013-04-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1550-2783-10-22</dc:identifier>
                                <prism:require>/content/figures/1550-2783-10-22-toc.gif</prism:require>
                <prism:publicationName>Journal of the International Society of Sports Nutrition</prism:publicationName>
        <prism:issn>1550-2783</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>22</prism:startingPage>
        <prism:publicationDate>2013-04-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jissn.com/content/10/1/21">
        <title>Effect of HX108-CS supplementation on exercise capacity and lactate accumulation after high-intensity exercise</title>
        <description>Background:
In the present study, we determined the effects of HX108-CS (mixed extract of Schisandra chinensis and Chaenomeles sinensis) supplementation on lactate accumulation and endurance capacity. Furthermore, we examined CK (creatine kinase), LDH (lactate dehydrogenase) activity to determine whether the HX108-CS affected markers of skeletal muscle injury in vivo and in vitro.
Methods:
Exercise capacity was measured by an exhaustive swimming test using ICR mice divided into four groups; one group received distilled water (DW) (Control group, n&#8201;=&#8201;10), and the other groups received three different dosages of HX108-CS (10, 50 and 100&#8201;mg/kg, n&#8201;=&#8201;10 per group) solution in water orally. Then, for the time-dependent measurements of blood lactate, CK, and LDH, Sprague&#8211;Dawley rats were divided into two groups; one received DW (Control group, n&#8201;=&#8201;10), and the other group received HX108-CS (100&#8201;mg/kg, n&#8201;=&#8201;10) solution in the same way as mice. Before the exercise test, the animals were given either DW or HX108-CS for 2&#8201;weeks. High-intensity treadmill exercise was performed for 30&#8201;minutes. Blood samples were collected and analyzed during and after exercise. For the in vitro experiment, C2C12 cells were treated with HX108-CS to examine its effect on lactate production, CK, and LDH activity.
Results:
Blood lactate concentration was significantly lowered immediately after treadmill exercise in HX108-CS group; however, there were no significant differences in activities of CK and LDH between HX108-CS and control during treadmill exercise and recovery phase. Furthermore, treatment with 100&#8201;mg/kg of HX108-CS led to a significant increase in the time to exhaustion in swimming test, and concurrently blood lactate concentration was significantly decreased in 50 and 100&#8201;mg/kg treated group. Moreover, our results of in vitro experiment showed that HX108-CS suppressed lactate production, CK, and LDH activity in a dose-dependent manner.
Conclusions:
These results suggest that supplementation with HX108-CS may enhance exercise capacity by lowering lactate accumulation. This may in part be related to an amelioration of skeletal muscle injury.</description>
        <link>http://www.jissn.com/content/10/1/21</link>
                <dc:creator>Seung-Lyul Oh</dc:creator>
                <dc:creator>Hyukki Chang</dc:creator>
                <dc:creator>Hee-Jae Kim</dc:creator>
                <dc:creator>Yong-An Kim</dc:creator>
                <dc:creator>Dong-Sik Kim</dc:creator>
                <dc:creator>Seong-Hyun Ho</dc:creator>
                <dc:creator>Seon-Hee Kim</dc:creator>
                <dc:creator>Wook Song</dc:creator>
                <dc:source>Journal of the International Society of Sports Nutrition 2013, null:21</dc:source>
        <dc:date>2013-04-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1550-2783-10-21</dc:identifier>
                                <prism:require>/content/figures/1550-2783-10-21-toc.gif</prism:require>
                <prism:publicationName>Journal of the International Society of Sports Nutrition</prism:publicationName>
        <prism:issn>1550-2783</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>21</prism:startingPage>
        <prism:publicationDate>2013-04-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jissn.com/content/10/1/20">
        <title>Dietary nucleotide improves markers of immune response to strenuous exercise under a cold environment</title>
        <description>Background:
Strenuous exercise has been classically associated to immune-suppression and consequently to an increased risk of infections, especially at the upper respiratory tract. The administration of dietary nucleotides has been demonstrated useful to maintain the immune function in situations of stress and thus could be an appropriate strategy to counteract the decline of the immune function associated to strenuous exercise. The aim of the present study was to asses the impact of a specific nucleotide formulation (Inmunactive&#174;) on the markers of immune function of athletes after a heavy exercise bout under cold conditions.
Methods:
Twenty elite male taekwondo athletes were randomly divided into two groups of 10 subjects that were supplemented with placebo (P) or Inmunactive (I) at 480 mg/day during 30 days. At baseline (day 0) and after 4 wk of supplementation (day 30) each subject undertook an exhaustion exercise test using a cycloergometer. Skin temperature, core temperature, heart rate, lactate concentration and rating of perceived exertion (RPE) were recorded during the test. Blood and saliva samples were obtained before and after each exercise test for determination of blood cell concentrations, PHA-stimulated lymphocyte proliferation (PHA-LP) and salivary immunoglobulin A (SIgA).
Results:
Exercise tests induced neutrophilia and reduction in lymphocyte blood counts on day 0 and on day 30 in both groups. However, the I group exhibited a faster recovery from the lymphopenic response than the P group, so that lymphocyte levels were higher after 150 min (P&#8201;&lt;&#8201;0.0028). Furthermore, the lymphoproliferative response was modulated by nucleotide supplementation, since it was higher in the I group on day 30 despite an almost significant (P&#8201;&lt;&#8201;0.06) exercise-evoked decrease at baseline.
Conclusions:
These findings suggest that supplementation with a nucleotide-based product for 4 weeks could counteract the impairment of immune function after heavy exercise.</description>
        <link>http://www.jissn.com/content/10/1/20</link>
                <dc:creator>Joan Riera</dc:creator>
                <dc:creator>Victoria Pons</dc:creator>
                <dc:creator>Daniel Martinez-Puig</dc:creator>
                <dc:creator>Carlos Chetrit</dc:creator>
                <dc:creator>Josep Tur</dc:creator>
                <dc:creator>Antoni Pons</dc:creator>
                <dc:creator>Franchek Drobnic</dc:creator>
                <dc:source>Journal of the International Society of Sports Nutrition 2013, null:20</dc:source>
        <dc:date>2013-04-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1550-2783-10-20</dc:identifier>
                                <prism:require>/content/figures/1550-2783-10-20-toc.gif</prism:require>
                <prism:publicationName>Journal of the International Society of Sports Nutrition</prism:publicationName>
        <prism:issn>1550-2783</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>20</prism:startingPage>
        <prism:publicationDate>2013-04-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jissn.com/content/10/1/19">
        <title>Proteomic analysis of plasma after branched chain enriched mixture supplementation in mice</title>
        <description>Background:
Branched chain amino acid (BCAA) supplementation is a recently identified strategy to promote longevity in mice. A proteomic approach was used to identify proteins which are differentially expressed in the sera of mice following supplementation with selected branched chain amino acid enriched mixture (BCAAem).Findings12 male mice (C57Bl6, 9&#160;months-old) were randomly assigned to unsupplemented (Control, n&#8201;=&#8201;6) and supplemented (BCAA, n&#8201;=&#8201;6, 0.1&#160;mg/gr/day in drink water for 4&#160;weeks). At the end of treatment total plasma samples from Control and BCAAem mice were separated by two-dimensional gel electrophoresis (2-DE). After staining, the gels were imaged and differential protein expression patterns were interrogated using image analysis software. Spots showing a different expression level were identified through a comparison with 2D maps found in databases officially recognized (ExPASy).Master gels of Control and BCAA mice exhibited slightly different 2-DE patterns as only 10 spots out of 500 appeared differentially expressed: 8 were upregulated (corresponding to Apolipoprotein A-I (APOA1), Complement factor B, Complement C3, Immunoglobulin light chain) and 2 appeared downregulated (Alpha-1-antitrypsin and unknown).
Conclusions:
Supplementation with BCAAem in mice results in a slight perturbation of the host serum proteome. Of particular interest is the increased Apolipoprotein A-I (APOAI) following treatment.</description>
        <link>http://www.jissn.com/content/10/1/19</link>
                <dc:creator>Lorenza Brocca</dc:creator>
                <dc:creator>Anna Mascaro</dc:creator>
                <dc:creator>Giuseppe D¿Antona</dc:creator>
                <dc:source>Journal of the International Society of Sports Nutrition 2013, null:19</dc:source>
        <dc:date>2013-04-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1550-2783-10-19</dc:identifier>
                                <prism:require>/content/figures/1550-2783-10-19-toc.gif</prism:require>
                <prism:publicationName>Journal of the International Society of Sports Nutrition</prism:publicationName>
        <prism:issn>1550-2783</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>19</prism:startingPage>
        <prism:publicationDate>2013-04-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jissn.com/content/10/1/17">
        <title>The influence of commercially-available carbohydrate and carbohydrate-protein supplements on endurance running performance in recreational athletes during a field trial</title>
        <description>Background:
It is recommended that endurance athletes consume carbohydrate (CHO) supplements, providing 6-8% CHO concentration, during exercise&#8201;&gt;&#8201;60&#8201;minutes to improve athletic performance. Recently research has compared carbohydrate-protein (CHO-P) supplementation to the traditionally used CHO supplementation during endurance exercise, following these supplementation recommendations, in controlled settings, but not under simulated applied conditions such as a field trial. Therefore, the purpose of the present investigation was to test CHO and CHO-P supplementation under applied conditions such that commercially-available isocaloric (CHO-P &amp; double-carbohydrate [CHO-CHO]) and isocarbohydrate (CHO-P &amp; CHO) supplements were compared to a placebo (PLA), within an outdoor running field trial&#8201;&gt;&#8201;60&#8201;minutes in order to asses their influence on endurance performance.
Methods:
Twelve male recreational runners completed four, 19.2&#8201;km runs, where they were instructed to run at a pace similar to race pace including a final sprint to the finish, which in this case was the final two laps of the course (1.92&#8201;km). Supplementation was provided before the start and in 4&#8201;km increments. Performance was measured by time to complete the 19.2&#8201;km run and last 1.92&#8201;km sprint.
Results:
Analyses found no difference between supplements in time to complete the 19.2&#8201;km run (PLA&#8201;=&#8201;88.6&#8201;&#177;&#8201;11.6&#8201;min, CHO&#8201;=&#8201;89.1&#8201;&#177;&#8201;11.3&#8201;min, CHO-P&#8201;=&#8201;89.1&#8201;&#177;&#8201;11.8&#8201;min, CHO-CHO&#8201;=&#8201;89.6&#8201;&#177;&#8201;11.9&#8201;min) or last 1.92&#8201;km sprint to the finish (PLA&#8201;=&#8201;8.3&#8201;&#177;&#8201;1.2&#8201;min, CHO&#8201;=&#8201;8.2&#8201;&#177;&#8201;1.2&#8201;min, CHO-P&#8201;=&#8201;8.2&#8201;&#177;&#8201;1.2&#8201;min, CHO-CHO&#8201;=&#8201;8.4&#8201;&#177;&#8201;1.5&#8201;min).
Conclusions:
When following recommendation for supplementation within a field trial, commercially available CHO and CHO-P supplements do not appear to enhance performance in male recreational runners.</description>
        <link>http://www.jissn.com/content/10/1/17</link>
                <dc:creator>Adriana Coletta</dc:creator>
                <dc:creator>Dixie Thompson</dc:creator>
                <dc:creator>Hollie Raynor</dc:creator>
                <dc:source>Journal of the International Society of Sports Nutrition 2013, null:17</dc:source>
        <dc:date>2013-03-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1550-2783-10-17</dc:identifier>
                                <prism:require>/content/figures/1550-2783-10-17-toc.gif</prism:require>
                <prism:publicationName>Journal of the International Society of Sports Nutrition</prism:publicationName>
        <prism:issn>1550-2783</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>17</prism:startingPage>
        <prism:publicationDate>2013-03-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
